Related Experiment Video

Updated: Dec 6, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.7K

Elevated miR-16-5p induces somatostatin receptor 2 expression in neuroendocrine tumor cells

HanHee Jo1,2, Yusun Park1, Jisu Kim1

  • 1Division of Life Sciences, College of Life Science and Bioengineering, Incheon National University, Incheon, South Korea.

Plos One
|October 12, 2020
PubMed

Insights

MicroRNAs regulate somatostatin receptor 2 (SSTR2) expression in neuroendocrine tumor cells. Upregulating miR-16-5p enhances octreotide sensitivity, potentially improving treatment for patients unresponsive to somatostatin analogs.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Somatostatin analogs are vital for neuroendocrine tumor (NET) treatment, yet patient response varies.
  • Differential expression of somatostatin receptors (SSTRs), particularly SSTR2, is a key factor influencing treatment efficacy.
  • Understanding SSTR2 regulation is crucial for optimizing somatostatin analog therapy.

Purpose of the Study:

  • To investigate the regulatory mechanism of somatostatin receptor 2 (SSTR2) expression.
  • To determine the role of microRNAs (miRNAs) in response to octreotide treatment.
  • To explore the potential of miR-16-5p as a therapeutic target for enhancing octreotide efficacy in neuroendocrine tumors.

Main Methods:

  • Neuroendocrine cells (INS-1) were treated with octreotide and placebo.
  • MicroRNA expression profiling was performed to identify dysregulated miRNAs.
  • In vitro experiments using transfected mimics assessed the impact of miR-16-5p on SSTR2 expression and cell proliferation.

Main Results:

  • Octreotide treatment led to dysregulation of 30 miRNAs in INS-1 cells.
  • miR-16-5p was significantly upregulated after short-term octreotide exposure.
  • Overexpression of miR-16-5p increased SSTR2 expression and enhanced octreotide's antiproliferative effect.

Conclusions:

  • miR-16-5p plays a crucial role in regulating SSTR2 expression.
  • Upregulating miR-16-5p can enhance sensitivity to octreotide treatment.
  • This finding offers a potential strategy to improve therapeutic outcomes for patients with neuroendocrine tumors unresponsive to current treatments.

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.0K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.7K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K